Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension
Clinical trial NCT00637403 · TERMINATED
Trial details
- NCT number
- NCT00637403
- Sponsor
- Par Pharmaceutical, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2006-05-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.